Curtis Nickel, MD

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    OM Pharma
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/28/2022

Pages

Return to Update Series (2022) Lesson 21: The Changing Role of Fluoroquinolones for Prophylaxis and Treatment of Urological Infections